The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of LB-100 plus doxorubicin as first-line of advanced soft tissue sarcomas: A Spanish Sarcoma Group (GEIS) study.
 
Javier Martin Broto
Leadership - Sarcoma Research Solutions SL
Consulting or Advisory Role - Amgen; Asofarma; Bayer; Boehringer Ingelheim; Cogent Medicine; GlaxoSmithKline; Lilly; Novartis; PharmaMar; Roche; Tecnofarma
Speakers' Bureau - PharmaMar
Research Funding - Adaptimmune; Amgen (Inst); Arog (Inst); Ayala Pharmaceuticals (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); CEBIOTEX (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Eisai; Eisai (Inst); FORMA Therapeutics (Inst); GlaxoSmithKline (Inst); Immix BioPharma (Inst); InhibRx (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Nektar (Inst); Novartis; Novartis (Inst); Pfizer (Inst); PharmaMar; PharmaMar (Inst); Philogen (Inst); PTC Therapeutics (Inst); Rain Therapeutics (Inst); SpringWorks Therapeutics (Inst)
Expert Testimony - Novartis; PharmaMar
Travel, Accommodations, Expenses - Pfizer; PharmaMar
 
Raul Terés
Consulting or Advisory Role - Deciphera; SynOX
Speakers' Bureau - PharmaMar
Travel, Accommodations, Expenses - Deciphera; PharmaMar; Roche
 
Gloria Marquina
Honoraria - AstraZeneca; AstraZeneca; AstraZeneca Spain; Deciphera; Eisai; Eisai; Eisai; Eisai; Eisai; GlaxoSmithKline; GlaxoSmithKline; Grunenthal; Grunenthal; Ipsen; Lilly; MSD; MSD; MSD Oncology; PharmaMar; Roche; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Eisai; GlaxoSmithKline; Karyopharm Therapeutics; PharmaMar; PharmaMar; Tesaro
Travel, Accommodations, Expenses - Angelini Pharma; Clovis Oncology; Eisai; Eisai; Lilly; Lilly; Lilly; Merck; MSD; MSD; Pfizer; Pfizer; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; Roche; Roche; Roche; Roche; Roche; Roche; Roche; Tesaro; Tesaro
Other Relationship - GlaxoSmithKline; Tesaro; Tesaro
 
Jose Perez-Fidalgo
Consulting or Advisory Role - Abbvie; AstraZeneca; Clovis Oncology; Deciphera; Eisai; GlaxoSmithKline; Karyopharm Therapeutics; MSD; Pharmaand; Regeneron
Speakers' Bureau - AstraZeneca Spain; Clovis Oncology; Eisai; GlaxoSmithKline; MSD Oncology; PharmaMar; Seagen
Research Funding - AstraZeneca Spain (Inst); GlaxoSmithKline (Inst); Pharmamar (Inst)
Patents, Royalties, Other Intellectual Property - Pending patent
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Pfizer; Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca Spain; Novartis
 
Carlos Lopez-Jimenez
Travel, Accommodations, Expenses - Deciphera; PharmaMar
 
Jose Luis Alonso-Romero
No Relationships to Disclose
 
Andres Redondo
Consulting or Advisory Role - Abbvie; AstraZeneca; Eisai; GlaxoSmithKline; MSD; Pharma&
Speakers' Bureau - Abbvie; AstraZeneca; GlaxoSmithKline; MSD; pharma&
Travel, Accommodations, Expenses - AstraZeneca
 
Antonio Gutierrez
No Relationships to Disclose
 
Antonio Casado
Consulting or Advisory Role - AstraZeneca; Eisai
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar
 
Ana Sebio
Honoraria - Deciphera; SpringWorks Therapeutics
Consulting or Advisory Role - Deciphera; SpringWorks Therapeutics
Travel, Accommodations, Expenses - Merck
 
Patricio Ledesma
Employment - Sofpromed Investigacion Clinica, SL (I)
Leadership - Sofpromed Investigacion Clinica, SL
Stock and Other Ownership Interests - Sofpromed Investigacion Clinica, SL
Honoraria - Sofpromed Investigacion Clinica, SL
Research Funding - Advenchen Laboratories (Inst); Blueprint Medicines (Inst); Karyopharm Therapeutics (Inst); Philogen (Inst)
 
Jose Angel Merino-Garcia
No Relationships to Disclose
 
Empar Mayordomo
No Relationships to Disclose
 
David Moura
Honoraria - Tecnofarma
Research Funding - Cogent Medicine (Inst); PharmaMar (Inst); SynOX (Inst)
Travel, Accommodations, Expenses - Bayer; Biosplice; Pfizer; PharmaMar
 
Nadia Hindi
Honoraria - Deciphera; PharmaMar
Consulting or Advisory Role - Deciphera; PharmaMar
Research Funding - Abbisko Therapeutics (Inst); Adaptimmune (Inst); Ayala Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb/Pfizer (Inst); CEBIOTEX (Inst); Cogent Biosciences (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Pfizer (Inst); PharmaMar (Inst); Philogen (Inst); PTC Therapeutics (Inst); Rain Therapeutics (Inst); SynOX (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim Spain; Deciphera; PharmaMar